Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Osteoarthritis review identifies links between dogs and humans
Humans and dogs share the most common areas for the development of OA.
‘One Health’ study could lead to new understanding and treatments

Key similarities between osteoarthritis (OA) in humans and dogs have been identified by researchers for the first time.

Scientists say their findings, published in Nature Reviews Rheumatology, may be in part due to the shared lifestyles of humans and dogs. However, their similar disease physiology and anatomies could also play a role.

The study was led by researchers at the RVC who conducted a comprehensive review of the existing literature related to OA. The team amalgamated more than 230 peer-reviewed studies into one single paper, ‘The spontaneous dog osteoarthritis - a one medicine vision.

Researchers found that humans and dogs share the most common areas for the development of OA - the hip, knee, shoulder and elbows. They also identified similarities in the pain experienced by dogs and humans, suggesting that our nervous systems function in the same way.

The team hopes that by combining this knowledge into one paper, it could lead to future collaborative studies by animal and human health experts. This ‘One medicine’ approach could then lead to new treatments to improve the welfare of both animals and humans.

Dr Richard Meeson from the RVC, who led the research said: “Pet dogs live with us and develop many of the same diseases as humans, such as arthritis.

“There is a growing belief, therefore, that a ‘one medicine’ approach to many of these diseases has the potential to unlock new understanding and treatments for both animals and humans. The potential for this approach has been clearly demonstrated in our review.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.